These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9329681)

  • 41. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease.
    de la Torre JC
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S72-81. PubMed ID: 10850734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
    Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
    Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrovasculature-mediated neuronal cell death.
    Grammas P; Reimann-Philipp U; Weigel PH
    Ann N Y Acad Sci; 2000 Apr; 903():55-60. PubMed ID: 10818489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebral vessels in ageing and Alzheimer's disease.
    Kalaria RN
    Pharmacol Ther; 1996; 72(3):193-214. PubMed ID: 9364575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging.
    de la Torre JC
    Gerontology; 1997; 43(1-2):26-43. PubMed ID: 8996828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
    Lourenço CF; Ledo A; Barbosa RM; Laranjinha J
    Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
    Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.
    de la Monte SM; Sohn YK; Etienne D; Kraft J; Wands JR
    Ann N Y Acad Sci; 2000 Apr; 903():61-71. PubMed ID: 10818490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies.
    Szpak GM; Lewandowska E; Wierzba-Bobrowicz T; Bertrand E; Pasennik E; Mendel T; Stepień T; Leszczyńska A; Rafałowska J
    Folia Neuropathol; 2007; 45(4):192-204. PubMed ID: 18176893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    Zhai Y; Yamashita T; Nakano Y; Sun Z; Shang J; Feng T; Morihara R; Fukui Y; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016 Jun; 53(3):893-905. PubMed ID: 27314529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The blood-brain barrier and cerebral microcirculation in Alzheimer disease.
    Kalaria RN
    Cerebrovasc Brain Metab Rev; 1992; 4(3):226-60. PubMed ID: 1389957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
    Davis DG; Schmitt FA; Wekstein DR; Markesbery WR
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):376-88. PubMed ID: 10218633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.
    Wiesmann M; Roelofs M; van der Lugt R; Heerschap A; Kiliaan AJ; Claassen JA
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2396-2413. PubMed ID: 27596834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
    Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
    J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salidroside prevents cognitive impairment induced by chronic cerebral hypoperfusion in rats.
    Yan ZQ; Chen J; Xing GX; Huang JG; Hou XH; Zhang Y
    J Int Med Res; 2015 Jun; 43(3):402-11. PubMed ID: 25858674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.
    Ramos-Miguel A; Sawada K; Jones AA; Thornton AE; Barr AM; Leurgans SE; Schneider JA; Bennett DA; Honer WG
    Acta Neuropathol; 2017 Mar; 133(3):395-407. PubMed ID: 27866231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Permanent, 3-stage, 4-vessel occlusion as a model of chronic and progressive brain hypoperfusion in rats: a neurohistological and behavioral analysis.
    Neto CJ; Paganelli RA; Benetoli A; Lima KC; Milani H
    Behav Brain Res; 2005 May; 160(2):312-22. PubMed ID: 15863227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol.
    Lapi D; Marchiafava PL; Colantuoni A
    J Vasc Res; 2008; 45(2):89-102. PubMed ID: 17934320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.